FDA Panel Rejects Avastin For Breast Cancer

    A Food and Drug Administration panel today voted 6-0 to halt the use of cancer drug Avastin for the treatment of breast cancer, saying studies have failed to show Avastin is effective for that purpose.  The recommendation came after two days of testimony from patients, doctors, and advocacy groups. The panel faced several tearful accounts of women, young and old, who believed Avastin saved their lives. Dozens of protesters, | Read More »

    FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug

    From the diaries by lexington_concord… Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective. The most dangerous period of time | Read More »

    FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug

    From the diaries by lexington_concord… Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective. The most dangerous period of time | Read More »

    Feds Deciding When Healthcare Science Costs Too Much To Save Lives

    If anyone wants a current example of what is looming ahead for medical science at the hands of Obamacare, the Avastin controversy is a perfect one. The Food and Drug Administration (FDA) wants to de-list the cancer drug Avastin one reason being that it is a drug too expensive for government to fund. It is scary to think that the federal government can summarily dismiss | Read More »

    Avastin Sticker Shock

    Avastin is a cancer drug developed by Roche Holding AG. It is also a costly drug. Avastin is used successfully for certain types of cancer (colorectal, lung, kidney, brain, and breast). It’s that last one that is raising eyebrows.

    Obamacare created a new Independent Medicare Advisory Board (IMAB) to ‘curtail spending’. Now, on advice from the IMAB, the FDA is considering restricting Avastin. It is amazing to see the range of responses from the left here in America.

    Read More →

    Read More »

    Avastin Sticker Shock

    Avastin is a cancer drug developed by Roche Holding AG. It is also a costly drug. Avastin is used successfully for certain types of cancer (colorectal, lung, kidney, brain, and breast). It’s that last one that is raising eyebrows.

    Obamacare created a new Independent Medicare Advisory Board (IMAB) to ‘curtail spending’. Now, on advice from the IMAB, the FDA is considering restricting Avastin. It is amazing to see the range of responses from the left here in America.

    Read More →

    Read More »

    Obamacare worth 17.5K dead women a year?

    If you’ve missed the Avastin controversy, here’s a quick summary of it: Avastin is a general anti-cancer drug that got fast-tracked by the FDA a few years ago and is now prescribed to under 18 thousand women a year in the United States who suffer from the last stages of breast cancer.  It doesn’t cure the cancer; it has side effects; and its beneficial effects | Read More »

    Obamacare worth 17.5K dead women a year?

    If you’ve missed the Avastin controversy, here’s a quick summary of it: Avastin is a general anti-cancer drug that got fast-tracked by the FDA a few years ago and is now prescribed to under 18 thousand women a year in the United States who suffer from the last stages of breast cancer.  It doesn’t cure the cancer; it has side effects; and its beneficial effects | Read More »